Cynomorium songaricum extracts functionally modulate transporters of γ-aminobutyric acid and monoamine

Neurochemical Research

Volumn 35, Issue 4, 2010, Pages 666-676

  Zhao, Gang ^a,b   Wang, Jie ^a   Qin, Guo Wei ^c   Guo, Li He ^a,b  

^a Cell Star Bio Technologies Co Limited   (China)

^b INSTITUTE OF BIOCHEMISTRY AND CELL BIOLOGY   (China)

^c SHANGHAI INSTITUTE OF MATERIA MEDICA   (China)

Author keywords

aminobutyric acid; Cynomorium songaricum Rupr.; Dopamine; Norepinephrine; Serotonin; Transporter modulator

Indexed keywords

1 [2 (BENZHYDRYLOXY)ETHYL] 4 (3 PHENYLPROPYL)PIPERAZINE; 4 AMINOBUTYRIC ACID; 4 AMINOBUTYRIC ACID CARRIER; ACETIC ACID ETHYL ESTER; ALCOHOL; BUTANOL; CHLOROFORM; CYNOMORIUM SONGARICUM EXTRACT; DESIPRAMINE; DOPAMINE; DOPAMINE TRANSPORTER; FLUOXETINE; HERBACEOUS AGENT; NORADRENALIN; NORADRENALIN TRANSPORTER; PETROLEUM ETHER; SEROTONIN; SEROTONIN TRANSPORTER; TIAGABINE; UNCLASSIFIED DRUG;

4 AMINOBUTYRIC ACID UPTAKE; ANIMAL CELL; ARTICLE; BRAIN SYNAPTOSOME; CHO CELL; CONTROLLED STUDY; CYNOMORIUM; CYNOMORIUM SONGARICUM; DOPAMINE UPTAKE; DRUG EFFICACY; DRUG POTENCY; IC 50; NONHUMAN; NORADRENALIN UPTAKE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SEROTONIN UPTAKE; SOLVENT EXTRACTION; UPREGULATION;

ANIMALS; BRAIN; CHO CELLS; CRICETINAE; CRICETULUS; CYNOMORIUM; DOPAMINE PLASMA MEMBRANE TRANSPORT PROTEINS; GABA PLASMA MEMBRANE TRANSPORT PROTEINS; GAMMA-AMINOBUTYRIC ACID; NOREPINEPHRINE PLASMA MEMBRANE TRANSPORT PROTEINS; PLANT EXTRACTS; SEROTONIN; SEROTONIN PLASMA MEMBRANE TRANSPORT PROTEINS; SYNAPTOSOMES;

CRICETULUS GRISEUS; CYNOMORIUM SONGARICUM;

EID: 77953536800     PISSN: 03643190     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11064-009-0118-2     Document Type: Article

References (47)

1. Ma CM, Jia SS, Zhang YW et al (1992) Triterpenes and other constituents from Cynomorium songaricum. Chin Chem Lett 3: 281-282
2. Ma CM, Jia SS, Sun T et al (1993) Triterpenes and steroidal compounds from Cynomorium songaricum. Yao Xue Xue Bao 28: 152-155
3. Xu X, Zhang C, Li C (1996) Chemical components of Cynomorium sonaricum Rupr. Zhongguo Zhong Yao Za Zhi 121: 676-677
4. Zhang CZ, Xu XZ, Li C (1996) Fructosides from Cynomorium songaricum. Phytochemistry 41:975-976
5. Ma C, Nakamura N, Miyashiro H et al (1999) Inhibitory effects of constituents from Cynomorium songaricum and related triterpene derivatives on HIV-1 protease. Chem Pharm Bull (Tokyo) 47:141-145
6. Jiang ZH, Tanaka T, Sakamoto M et al (2001) Studies on a medicinal parasitic plant: lignans from the stems of Cynomorium songaricum. Chem Pharm Bull (Tokyo) 49:1036-1038
7. Zhang SJ, Zhang SY, Hu JP (2001) Studies on polysaccharide of Cynomorium songaricum Rupr. Zhongguo Zhong Yao Za Zhi 26: 409-411
8. Pierre S (2006) Herbal composition and method of use for promoting erections and treating erectile dysfunction in men. Patent: US 2006/0269623 A1
9. Tao J, Tu P, Xu W et al (1999) Studies on chemical constituents and pharmacological effects of the stem of Cynomorium songaricum Rupr. Zhongguo Zhong Yao Za Zhi 24:292-294
10. The Chinese Pharmacopoeia Commission (2005) Pharmacopoeia PRC. 1:241
11. Luo JD, Zhang RX, Jia ZP et al (2007) Pharmacological effects and mechanism of anti-hypoxia components from Cynomorium songaricum Rupr. Tradit Chin Drug Res Clin Pharmacol 18: 275-279
12. Zhou YB, Ye RR, Lu XF et al (2009) GC-MS analysis of liposoluble constituents from the stems of Cynomorium songaricum. J Pharm Biomed Anal 49:1097-1100
13. Zhang RX, Jia ZP, Li MX et al (2008) Study on the effect of Part III from Cynomorium songaricum on immunosuppressive mice induced by cyclophosphamide. Zhong Yao Cai 31:407-409
14. Wang ZB, Guo CC, Fu YP et al (2006) The effect of Cynomorium songaricum Rupr on endurance and antioxidative status of skeletal muscle in trained mice. J Northwest Norm Univ (Nat Sci) 42: 100-102
15. Jiao Y, Li CX, Ni LF et al (2007) Research of antioxidant action of the Cynomrium Songaricum Rupr polysaccharide. Food Sci Technol 32:113-115
16. Zhao YQ, Wang ZW, Jing YH (2002) The study on the effect of Suoyang on ultrastructural in the relevant brain areas of learning and memory in the rat's model of Alzheimer' disease. Chin J Clin Rehabil 6:2220-2221
17. Tian XM, Wang MF, Zhang T et al (2005) Effect of Cynomorium songaricum Rupr. on gene expression of NO, NOS, and bcl-2/bax in the brain of aging mice. Chin J Gerontol 25:446-447
18. Hu YL, Wang ZX, XiaoWL(2005) Studies on anti-anoxia and antiepilepsy of Cynomorium songaricum. J Shihezi Univ (Nat Sci) 23:302
19. Luo JD, Zhang RX, Jia ZP (2006) Evaluation of pharmacodynamics and pharmacological mechanism of anti-stress action of Cynomorium songaricum Rupr. Zhong Yao Cai 29:744-747
20. Yu FR, Feng ST, Xie MR et al (2008) Anti-fatigue effect of Cynomorium songaricum flavone on old rats. Chin J Rehabil Theory Prac 14:1141-1142
21. Marien MR, Colpaert FC, Rosenquist AC (2004) Noradrenergic mechanisms in neurodegenerative diseases: a theory. Brain Res Rev 45:38-78
22. Cohen-Kfir E, Lee W, Eskandari S et al (2005) Zinc inhibition of gamma-aminobutyric acid transporter 4 (GAT4) reveals a link between excitatory and inhibitory neurotransmission. Proc Natl Acad Sci USA 102:6154-6159
23. Asada H, Kawamura Y, Maruyama K et al (1997) Cleft palate and decreased brain gamma-aminobutyric acid in mice lacking the 67-kDa isoform of glutamic acid decarboxylase. Proc Natl Acad Sci USA 94:6496-6499
24. Hersch SM, Yi H, Heilman CJ et al (1997) Subcellular locallization and molecular topology of dopamine transporter in the striatum and substantia nigra. J Comp Neurol 388:211-227
25. Nelson N (1998) The family of Na+/Cl-neurotransmitter transporters. J Neurochem 71:1785-1803
26. Wang Q, Hou TJ (2007) Determination of protocatechuic acid in Cynomorium songaricum by HPLC. China Pharmacy 18:1170-1171
27. Liu Z, Wang Y, Zhao W et al (2001) Peptide derived from insulin with regulatory activity of dopamine transporter. Neuropharmacology 41:464-471
28. Zhao G, Zheng XW, Gai Y et al (2009) Safflower extracts functionally regulate monoamine transporters. J Ethnopharmacol 124:116-124
29. Zhao G, Jiang ZH, Zheng XW et al (2008) Dopamine transporter inhibitory and antiparkinsonian effect of common flowering quince extract. Pharmacol Biochem Behav 90:363-371
30. Zhao G, Zang SY, Zheng XW et al (2008) Bakuchiol analogs inhibit monoamine transporters and regulate monoaminergic functions. Biochem Pharmacol 75:1835-1847
31. Zhao G, Li S, Qin GW et al (2007) Inhibitive effects of Fructus Psoraleae extract on dopamine transporter and noradrenaline transporter. J Ethnopharmacol 112:498-506
32. Xu LF, Chu WJ, Qing XY et al (2006) Protopine inhibits serotonin transporter and noradrenaline transporter and has the antidepressant-like effect in mice models. Neuropharmacology 50: 934-940
33. Ding J, Shi J, Cui D et al (2006) Development of peptidic dopamine transporter inhibitors via aromatic modification-mediated conformational restriction. J Med Chem 49:4048-4051
34. Zhao G, Gai Y, Chu WJ et al (2009) A novel compound N(1), N(5)-(Z)-N(10)-(E)-tri-p-coumaroylspermidine isolated from Carthamus tinctorius L. and acting by serotonin transporter inhibition. Eur Neuropsychopharmacol 19:749-758
35. Zhao G, Qin GW, Wang J et al. (2010) Functional activation of monoamine transporters by luteolin and apigenin isolated from the fruit of Perilla frutescens (L.) Britt. Neurochem Int 56: 168-176
36. Torres GE (2006) The dopamine transporter proteome. J Neurochem 97:3-10
37. Gainetdinov RR, Caron MG (2003) Monoamine transporters: from genes to behavior. Annu Rev Pharmacol Toxicol 43: 261-284
38. Kienast T, Heinz A (2006) Dopamine and the diseased brain. CNS Neurol Disord Drug Targets 5:109-131
39. Nutt DJ, Bell CJ, Malizia AL (1998) Brain mechanisms of social anxiety disorder. J Clin Psychiatry 59(Suppl 17):4-11
40. Harsányi A, Csigó K, Demeter G et al (2007) New approach to obsessive-compulsive disorder: dopaminergic theories. Psychiatr Hung 22:248-258
41. Kauer JA, Malenka RC (2007) Synaptic plasticity and addiction. Nat Rev Neurosci 8:844-858
42. Goodman A (2008) Neurobiology of addiction. An integrative review. Biochem Pharmacol 75:266-322
43. Tatsumi M, Groshan K, Blakely RD et al (1997) Pharmacological profile of antidepressants and related compounds at human monoamine transporters. Eur J Pharmacol 340:249-258
44. Rudnick G, Wall SC (1991) Binding of the cocaine analog 2 beta-[3H]carboxymethoxy-3 beta-(4-fluorophenyl) tropane to the seronin transporter. Mol Pharmacol 40:421-426
45. Corchs F, Nutt DJ, Hood S et al (2009) Serotonin and sensitivity to trauma-related exposure in selective serotonin reuptake inhibitors-recovered posttraumatic stress disorder. Biol Psychiatry 66:17-24
46. Soudijn W, Van Wijngaarden I (2000) The GABA transporter and its inhibitors. Curr Med Chem 7:1063-1079
47. Thoeringer CK, Ripke S, Unschuld PG et al (2009) The GABA transporter 1 (SLC6A1): a novel candidate gene for anxiety disorders. J Neural Transm 116:649-657